explore -WSS

explore

author：explore 2025-10-01 11:00:24 - browse：2219

Slayman with (left to right) Dr. Leo Riella, Medical Director of Kidney Transplantation, Dr. Nahel Elias, Interim Chief, Division of Transplant Surgery, his partner, Faren, and Dr. Tatsuo Kawai, Director, Legorreta Center for Clinical Transplant Tolerance. -- HEALTH coverage from STAT — Rick Slayman, holding hands with his partner, Faren, poses with members of his Massachusetts General Hospital medical team before being going home last month. Michelle Rose/Massachusetts General Hospital

Rick Slayman, the first man to receive a kidney transplant from a genetically engineered pig, has died, according to a statement from his family and Massachusetts General Hospital, where he underwent the historic operation in March.

“Our family is deeply saddened about the sudden passing of our beloved Rick but take great comfort knowing he inspired so many,” his family said in the statement released Saturday evening.

The hospital did not say how or when Slayman died. A spokesperson declined to provide further information, citing “privacy issues.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

knowledge

WSS

Morphosys mixed study results for blood cancer drug

In key trial, Verve's treatment lowers cholesterol levels in patients

Hospitals owned by private equity see complications spike 25%

Why medical students are struggling with mental health

Congress must reauthorize a committee to support older Americans

Virtual care provider acquires bankrupt Pear's prescription apps

explore

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

focus

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Bristol Myers buys into radiopharmaceuticals with RayzeBio

23andMe had bad news about my health. I wish a person had delivered it

Morphosys mixed study results for blood cancer drug

Trump demands the U.S. pay no more for drugs than other countries … again

Anthos stroke drug appears safer than common blood thinner

Moonlake's readout produced a cash windfall. Risks remain

In Spain, a hospital brews its own CAR

ChatGPT in medicine: STAT answers readers' burning questions

Ransomware attacks on hospitals: Study outlines patient impact

explore

NYU radiologists take on the challenge of expensive MRI machines

Prime Medicine, Myeloid Therapeutics clash over genome

In Spain, a hospital brews its own CAR

Does good food count as health care? Study aims to find out

Astellas still sees hope in its gene therapy after four deaths

Bristol Myers buys into radiopharmaceuticals with RayzeBio

explore

knowledge

hotspot

knowledge